| 查看: 567 | 回复: 1 | |||
jinqingxian至尊木虫 (著名写手)
有机脑力学-合成手艺学
|
[交流]
安帕来斯
|
| 谁知道安帕来斯的情况，是否允许上市？国内还是国外？销售和疗效情况如何？ |
回复此楼» 猜你喜欢
文献求助
已经有1人回复
-
如何高效的测量腺病毒的粒径和电位
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有213人回复
-
26在职申博—生物与医药—抗体/ADC药物方向，江浙沪，有项目，可带资。
已经有1人回复
thecoldest
金虫 (正式写手)
- 应助: 148 (高中生)
- 金币: 1772.7
- 散金: 30
- 红花: 33
- 帖子: 588
- 在线: 116.3小时
- 虫号: 1119567
- 注册: 2010-10-11
- 专业: 药物分析
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
小木虫: 金币+0.5, 给个红包，谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
|
应该是因临床试验效果不好，被原研制方Cortex放弃了 http://www.trademarkia.com/ampakine-77965906.html ABANDONED - NO STATEMENT OF USE FILED 11/5/2012 https://en.wikipedia.org/wiki/CX-516 CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and is being developed by a collaboration of Cortex and Shire and Servier. It was researched as a treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD. CX-516 was the first ampakine compound developed by Cortex and while it showed good in vitro activity and positive results in animal tests, the human trials proved disappointing due mainly to low potency and short half-life. However, CX-516 is still widely used in animal research into the ampakine drugs and is the standard reference compound that newer, more potent drugs of this class such as farampator and CX-717 are compared to. |
2楼2016-01-03 09:48:42